Aptose Biosciences Files 8-K
Ticker: APTOF · Form: 8-K · Filed: May 28, 2025 · CIK: 882361
Sentiment: neutral
Topics: corporate-governance, financial-reporting, regulatory-filing
Related Tickers: APTO
TL;DR
APTO filed an 8-K on May 28th covering votes, Reg FD, and financials.
AI Summary
Aptose Biosciences Inc. filed an 8-K on May 28, 2025, reporting on matters submitted to a vote of security holders, Regulation FD disclosures, and financial statements and exhibits. The filing pertains to events occurring on May 27, 2025. The company is incorporated in Canada and its fiscal year ends on December 31.
Why It Matters
This 8-K filing provides updates on corporate governance and financial matters for Aptose Biosciences Inc., which could impact investor understanding of the company's operations and strategic direction.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting on standard corporate events and disclosures, not indicating any immediate material adverse changes.
Key Players & Entities
- Aptose Biosciences Inc. (company) — Registrant
- May 27, 2025 (date) — Earliest event reported
- May 28, 2025 (date) — Date of report
- 0000882361 (company_id) — Central Index Key
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the excerpt.
What is the primary business of Aptose Biosciences Inc. according to its SIC code?
Aptose Biosciences Inc.'s Standard Industrial Classification (SIC) code is 2836, which corresponds to 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)'.
When is Aptose Biosciences Inc.'s fiscal year end?
Aptose Biosciences Inc.'s fiscal year ends on December 31.
What is the filing date of this 8-K report?
The 8-K report was filed as of May 28, 2025.
What are the previous names of Aptose Biosciences Inc. and their name change dates?
Aptose Biosciences Inc. was formerly known as Aptose Biosciences Inc. (formerly LORUS THERAPEUTICS INC.) with a name change date of 20140905, LORUS THERAPEUTICS INC. with a name change date of 19990308, and IMUTEC PHARMA INC with a name change date of 19970113.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 28, 2025 regarding Aptose Biosciences Inc. (APTOF).